Hiroyuki Imaki
- Molecular Biology top 10%
- Oncology top 5%
- Cell Biology top 5%
- Immunology
- Cancer Research
- Co-authors
- Keiko NakayamaKeiichi I. NakayamaShigetsugu HatakeyamaTakumi KamuraMasayoshi YadaN. IshidaFumihiko OkumuraMasaaki Nishiyama
- Topics
- Ubiquitin and proteasome pathways (4 papers)Cancer-related Molecular Pathways (2 papers)Glaucoma and retinal disorders (2 papers)
- Cited by
- AgingOncologyMolecular Biology
- Partner nations
- JapanUnited States
In The Last Decade
Hiroyuki Imaki
8 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Molecular Biology 1.1k
- Oncology 510
- Cell Biology 220
- Immunology 207
- Cancer Research 155
Countries citing papers authored by Hiroyuki Imaki
This map shows the geographic impact of Hiroyuki Imaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Imaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Imaki more than expected).
Fields of papers citing papers by Hiroyuki Imaki
This network shows the impact of papers produced by Hiroyuki Imaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Imaki. The network helps show where Hiroyuki Imaki may publish in the future.
Co-authorship network of co-authors of Hiroyuki Imaki
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyuki Imaki. A scholar is included among the top collaborators of Hiroyuki Imaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyuki Imaki. Hiroyuki Imaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 24 | |
| 3 | 13 | |
| 4 | Phosphorylation‐dependent degradation of c‐Myc is mediated by the F‐box protein Fbw7breakdown → | 660 |
| 5 | 250 | |
| 6 | Cell cycle-dependent regulation of the Skp2 promoter by GA-binding protein. | 76 |
| 7 | 63 | |
| 8 | 336 | |
| 9 | 7 |
About Hiroyuki Imaki
Hiroyuki Imaki is a scholar working on Aging, Ophthalmology and Parasitology, having authored 9 papers that have together received 1.4k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (4 papers), Cancer-related Molecular Pathways (2 papers) and Glaucoma and retinal disorders (2 papers). The work is most often cited by research in Aging (37 citations), Oncology (510 citations) and Molecular Biology (1.1k citations). Hiroyuki Imaki has collaborated with scholars based in Japan and United States. Frequent co-authors include Keiko Nakayama, Keiichi I. Nakayama, Shigetsugu Hatakeyama, Takumi Kamura, Masayoshi Yada, N. Ishida, Fumihiko Okumura, Masaaki Nishiyama, Ryosuke Tsunematsu and Tadasuke Tsukiyama. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.